Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
9,144
archived clinical trials in
Ocular

Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
1096
mi
from 02139
Stillwater, MN
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
1096
mi
from 02139
Stillwater, MN
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
189
mi
from 02139
Woodland Park, NJ
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
189
mi
from 02139
Woodland Park, NJ
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
334
mi
from 02139
Rochester, NY
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
334
mi
from 02139
Rochester, NY
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
650
mi
from 02139
High Point, NC
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
650
mi
from 02139
High Point, NC
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
547
mi
from 02139
Cleveland, OH
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
547
mi
from 02139
Cleveland, OH
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
915
mi
from 02139
Chattanooga, TN
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
915
mi
from 02139
Chattanooga, TN
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
1155
mi
from 02139
Houston, TX
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
1155
mi
from 02139
Houston, TX
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
mi
from 02139
Hemet, CA
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
mi
from 02139
Hemet, CA
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
mi
from 02139
Laguna Hills, CA
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
mi
from 02139
Laguna Hills, CA
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
mi
from 02139
Lancaster, CA
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
mi
from 02139
Lancaster, CA
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
mi
from 02139
Montebello, CA
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
mi
from 02139
Montebello, CA
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
mi
from 02139
Lexington, KY
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
mi
from 02139
Lexington, KY
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
mi
from 02139
Pennington, NJ
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
mi
from 02139
Pennington, NJ
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
mi
from 02139
Rockville Centre, NY
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
mi
from 02139
Rockville Centre, NY
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
mi
from 02139
Charlotte, NC
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
mi
from 02139
Charlotte, NC
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
mi
from 02139
Doylestown, PA
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
mi
from 02139
Doylestown, PA
Click here to add this to my saved trials
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated:  12/31/1969
SONATA Investigational Site
mi
from 02139
Mount Pleasant, SC
Safety Study of Lifitegrast to Treat Dry Eye
A Phase 3, Multicenter, Randomized, Double-Masked and Placebo-Controlled Study Evaluating the Safety of a 5.0% Concentration of Lifitegrast Ophthalmic Solution Compared to Placebo in Subjects With Dry Eye (SONATA)
Status: Enrolling
Updated: 12/31/1969
SONATA Investigational Site
mi
from 02139
Mount Pleasant, SC
Click here to add this to my saved trials
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic - Cole Eye Institute
544
mi
from 02139
Cleveland, OH
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic - Cole Eye Institute
544
mi
from 02139
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Columbia University Harkness Eye Institute
227
mi
from 02139
New York, NY
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Columbia University Harkness Eye Institute
227
mi
from 02139
New York, NY
Click here to add this to my saved trials
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Cornea & Laser Eye Institute; Hersh Vision Group
181
mi
from 02139
Teaneck, NJ
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Cornea & Laser Eye Institute; Hersh Vision Group
181
mi
from 02139
Teaneck, NJ
Click here to add this to my saved trials
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Durrie Vision
1252
mi
from 02139
Overland Park, KA
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Durrie Vision
1252
mi
from 02139
Overland Park, KA
Click here to add this to my saved trials
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Gordon -Weiss Vision Institute
2576
mi
from 02139
San Diego, CA
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Gordon -Weiss Vision Institute
2576
mi
from 02139
San Diego, CA
Click here to add this to my saved trials
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
Price Vision Group
801
mi
from 02139
Indianapolis, IN
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
Price Vision Group
801
mi
from 02139
Indianapolis, IN
Click here to add this to my saved trials
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
See Clearly Vision
396
mi
from 02139
McLean, VA
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
See Clearly Vision
396
mi
from 02139
McLean, VA
Click here to add this to my saved trials
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated:  12/31/1969
UPMC Eye Center
477
mi
from 02139
Pittsburgh, PA
Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus
A Multi-Center, Randomized, Placebo-Controlled Evaluation of the Safety and Efficacy of the KXL System With VibeX (Riboflavin Ophthalmic Solution) for Corneal Collagen Cross-Linking in Eyes With Keratoconus
Status: Enrolling
Updated: 12/31/1969
UPMC Eye Center
477
mi
from 02139
Pittsburgh, PA
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retinal Consultants of Southern California Medical Group, Inc.
2614
mi
from 02139
Westlake Village, CA
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retinal Consultants of Southern California Medical Group, Inc.
2614
mi
from 02139
Westlake Village, CA
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
National Ophthalmic Research Institute
1252
mi
from 02139
Fort Myers, FL
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
National Ophthalmic Research Institute
1252
mi
from 02139
Fort Myers, FL
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Central Florida Retina Institute
1161
mi
from 02139
Lakeland, FL
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Central Florida Retina Institute
1161
mi
from 02139
Lakeland, FL
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Ocala Eye Retina Consultants
1098
mi
from 02139
Ocala, FL
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Ocala Eye Retina Consultants
1098
mi
from 02139
Ocala, FL
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Thomas Eye Group
mi
from 02139
Atlanta, GA
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Thomas Eye Group
mi
from 02139
Atlanta, GA
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Southeast Retina Center, P.C.
851
mi
from 02139
Augusta, GA
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Southeast Retina Center, P.C.
851
mi
from 02139
Augusta, GA
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Raj K. Maturi, MD
800
mi
from 02139
Indianapolis, IN
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Raj K. Maturi, MD
800
mi
from 02139
Indianapolis, IN
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Wolfe Eye Clinic
1161
mi
from 02139
West Des Moines, IA
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Wolfe Eye Clinic
1161
mi
from 02139
West Des Moines, IA
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina and Vitreous Associates of Kentucky
766
mi
from 02139
Lexington, KY
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina and Vitreous Associates of Kentucky
766
mi
from 02139
Lexington, KY
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Paducah Retinal Center
996
mi
from 02139
Paducah, KY
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Paducah Retinal Center
996
mi
from 02139
Paducah, KY
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Elman Retina Group, PA
351
mi
from 02139
Baltimore, MD
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Elman Retina Group, PA
351
mi
from 02139
Baltimore, MD
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Henry Ford Health System, Dept of Ophthalmology and Eye Care Services
609
mi
from 02139
Detroit, MI
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Henry Ford Health System, Dept of Ophthalmology and Eye Care Services
609
mi
from 02139
Detroit, MI
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Vitrous Center
638
mi
from 02139
Grand Blanc, MI
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Vitrous Center
638
mi
from 02139
Grand Blanc, MI
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
The Retina Center
1118
mi
from 02139
Minneapolis, MN
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
The Retina Center
1118
mi
from 02139
Minneapolis, MN
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Eyesight Ophthalmic Services, PA
51
mi
from 02139
Portsmouth, NH
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Eyesight Ophthalmic Services, PA
51
mi
from 02139
Portsmouth, NH
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
The New York Eye and Ear Infirmary/Faculty Eye Practice
188
mi
from 02139
New York, NY
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
The New York Eye and Ear Infirmary/Faculty Eye Practice
188
mi
from 02139
New York, NY
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina-Vitreous Surgeons of Central New York, PC
260
mi
from 02139
Syracuse, NY
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina-Vitreous Surgeons of Central New York, PC
260
mi
from 02139
Syracuse, NY
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
724
mi
from 02139
Charlotte, NC
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Charlotte Eye Ear Nose and Throat Assoc, PA
724
mi
from 02139
Charlotte, NC
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Associates of Cleveland, Inc.
537
mi
from 02139
Beachwood, OH
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Associates of Cleveland, Inc.
537
mi
from 02139
Beachwood, OH
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
OSU Eye Physicians and Surgeons, LLC.
640
mi
from 02139
Columbus, OH
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
OSU Eye Physicians and Surgeons, LLC.
640
mi
from 02139
Columbus, OH
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Dean A. McGee Eye Institute
1489
mi
from 02139
Oklahoma City, OK
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Dean A. McGee Eye Institute
1489
mi
from 02139
Oklahoma City, OK
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Retina Northwest, PC
2530
mi
from 02139
Portland, OR
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Retina Northwest, PC
2530
mi
from 02139
Portland, OR
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Casey Eye Institute
2530
mi
from 02139
Portland, OR
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Casey Eye Institute
2530
mi
from 02139
Portland, OR
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Carolina Retina Center
789
mi
from 02139
Columbia, SC
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Carolina Retina Center
789
mi
from 02139
Columbia, SC
Click here to add this to my saved trials
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated:  12/31/1969
Palmetto Retina Center
786
mi
from 02139
Columbia, SC
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
A Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab and Ranibizumab for Diabetic Macular Edema
Status: Enrolling
Updated: 12/31/1969
Palmetto Retina Center
786
mi
from 02139
Columbia, SC
Click here to add this to my saved trials